Tudor Investment Corp’s Procter & Gamble PG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-4,533
| Closed | -$668K | – | 3926 |
|
|
2025
Q3 | $696K | Sell |
4,533
-224,240
| -98% | -$35M | ﹤0.01% | 2504 |
|
|
2025
Q2 | $36.4M | Buy |
228,773
+224,279
| +4,991% | +$36.6M | 0.08% | 180 |
|
|
2025
Q1 | $766K | Buy |
4,494
+1,038
| +30% | +$174K | ﹤0.01% | 2001 |
|
|
2024
Q4 | $579K | Sell |
3,456
-13,209
| -79% | -$2.25M | ﹤0.01% | 2124 |
|
|
2024
Q3 | $2.89M | Buy |
16,665
+11,960
| +254% | +$2.03M | 0.01% | 998 |
|
|
2024
Q2 | $776K | Buy |
+4,705
| New | +$769K | ﹤0.01% | 1595 |
|
|
2024
Q1 | – | Sell |
-109,304
| Closed | -$17.1M | – | 2659 |
|
|
2023
Q4 | $16M | Buy |
+109,304
| New | +$16.2M | 0.13% | 176 |
|
|
2023
Q3 | – | Sell |
-1,336
| Closed | -$204K | – | 2733 |
|
|
2023
Q2 | $203K | Buy |
+1,336
| New | +$201K | ﹤0.01% | 2228 |
|
|
2022
Q4 | – | Sell |
-55,295
| Closed | -$7.75M | – | 2735 |
|
|
2022
Q3 | $6.98M | Sell |
55,295
-26,029
| -32% | -$3.7M | 0.15% | 135 |
|
|
2022
Q2 | $11.7M | Buy |
+81,324
| New | +$12.2M | 0.31% | 29 |
|
|
2021
Q3 | – | Sell |
-95,592
| Closed | -$13.5M | – | 2721 |
|
|
2021
Q2 | $12.9M | Buy |
+95,592
| New | +$12.9M | 0.24% | 60 |
|
|
2021
Q1 | – | Sell |
-89,100
| Closed | -$12.4M | – | 1793 |
|
|
2020
Q4 | $12.4M | Buy |
+89,100
| New | +$12.5M | 0.35% | 31 |
|
|
2020
Q3 | – | Sell |
-27,555
| Closed | -$3.29M | – | 1489 |
|
|
2020
Q2 | $3.29M | Buy |
27,555
+22,194
| +414% | +$2.59M | 0.16% | 117 |
|
|
2020
Q1 | $590K | Sell |
5,361
-80,844
| -94% | -$9.7M | 0.05% | 425 |
|
|
2019
Q4 | $10.8M | Buy |
+86,205
| New | +$10.5M | 0.48% | 22 |
|
|
2019
Q3 | – | Sell |
-15,668
| Closed | -$1.72M | – | 1279 |
|
|
2019
Q2 | $1.72M | Buy |
+15,668
| New | +$1.67M | 0.05% | 381 |
|
|
2018
Q2 | – | Sell |
-28,512
| Closed | -$2.26M | – | 1187 |
|
|
2018
Q1 | $2.26M | Buy |
28,512
+7,790
| +38% | +$649K | 0.07% | 138 |
|
|
2017
Q4 | $1.9M | Buy |
20,722
+380
| +2% | +$34.2K | 0.05% | 182 |
|
|
2017
Q3 | $1.85M | Buy |
+20,342
| New | +$1.85M | 0.05% | 231 |
|
|
2017
Q2 | – | Sell |
-47,011
| Closed | -$4.22M | – | 1295 |
|
|
2017
Q1 | $4.22M | Buy |
47,011
+31,337
| +200% | +$2.78M | 0.13% | 110 |
|
|
2016
Q4 | $1.32M | Buy |
+15,674
| New | +$1.34M | 0.03% | 267 |
|
|
2016
Q3 | – | Sell |
-234,548
| Closed | -$19.9M | – | 1655 |
|
|
2016
Q2 | $19.9M | Buy |
234,548
+230,123
| +5,201% | +$18.9M | 0.42% | 28 |
|
|
2016
Q1 | $364K | Buy |
+4,425
| New | +$357K | 0.01% | 1167 |
|
|
2015
Q4 | – | Sell |
-135,959
| Closed | -$9.78M | – | 1787 |
|
|
2015
Q3 | $9.78M | Buy |
+135,959
| New | +$10.2M | 0.33% | 52 |
|
|
2015
Q2 | – | Sell |
-46,255
| Closed | -$3.79M | – | 1635 |
|
|
2015
Q1 | $3.79M | Buy |
46,255
+5,955
| +15% | +$512K | 0.12% | 95 |
|
|
2014
Q4 | $3.67M | Buy |
+40,300
| New | +$3.55M | 0.13% | 85 |
|
|
2014
Q2 | – | Sell |
-6,433
| Closed | -$518K | – | 1285 |
|
|
2014
Q1 | $518K | Sell |
6,433
-99,932
| -94% | -$7.87M | 0.02% | 503 |
|
|
2013
Q4 | $8.66M | Buy |
+106,365
| New | +$8.67M | 0.42% | 46 |
|
Other funds holding PG
VCM
VPM
Tudor Investment Corp's PG Position: Q4 2025 in Review
Tudor Investment Corp sold out of Procter & Gamble (PG) in Q4 2025, closing a stake of 4,533 shares — an estimated $668K sold.
Tudor Investment Corp first reported a position in PG in Q4 2013 and held it in 28 quarters. The position peaked at $36.4M in Q2 2025. 4,022 funds tracked by Wall St. Rank hold PG as of Q4 2025.
- Tudor Investment Corp reported no remaining Procter & Gamble position as of Q4 2025 after selling out during the quarter.
- Tudor Investment Corp sold 4,533 Procter & Gamble shares in Q4 2025, an estimated $668K.
- Tudor Investment Corp first reported a position in Procter & Gamble in Q4 2013 and held it in 28 quarters.
- Tudor Investment Corp's Procter & Gamble position peaked at $36.4M in Q2 2025.
- 4,022 funds tracked by Wall St. Rank held Procter & Gamble as of Q4 2025.
Based on Tudor Investment Corp's 13F filing for Q4 2025, filed 17 Feb 2026.